Skip to main content
Clinical Trials/NL-OMON43288
NL-OMON43288
Completed
N/A

Investigation of psychomotor performance to evaluate clinical impairment and pharmacokinetic aspects of methadone and buprenorphine: a double-blind placebo-controlled randomized trial - The acute effects of methadone and buprenorphine on driving

niversiteit Maastricht0 sites25 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
cognitief functioneren
Sponsor
niversiteit Maastricht
Enrollment
25
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Healthy males or females, in the opinion of the medical supervisor, based on a physical examination, medical history, vital signs, electrocardiogram, and the results of blood chemistry and hematology tests, and urinalysis
  • \- Aged between 23 and 50 years (inclusive)
  • \- BMI between 19 and 29 m2/kg (inclusive)
  • \- Possession of a valid driving license for 4 years or more
  • \- Driving experience of at least 5000 km per year on average
  • \- Good sleepers
  • \- Subjects should sign an Informed Consent Form

Exclusion Criteria

  • \- Sleep disorders such as insomnia and narcolepsy
  • \- History of or current drug or alcohol abuse
  • \- Current use of psycho\-active medication, and inability to stay abstinent during the study
  • \- Excessive alcohol use, defined as drinking more than 21 glasses of alcohol per week
  • \- Excessive caffeine use, defined as drinking 5 or more cups of coffee per day
  • \- Smoking more than 10 cigarettes per day
  • \- History or presence of drug/alcohol abuse, including experience with heroin, methadone and buprenorphine
  • \- Intake of any opioid within 3 months before the study
  • \- Use of any drug that is considered to influence the test drugs, including trade herbal products
  • \- History of severe allergic disease

Outcomes

Primary Outcomes

Not specified

Similar Trials